human rcd5l (R&D Systems)
Structured Review

Human Rcd5l, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5l/Recombinant+Human+CD5L+Protein%2C+CF/pm40544764-40-0-3
Average 93 stars, based on 5 article reviews
Images
1) Product Images from "CD5L is a target of transcription factor Nrf2."
Article Title: CD5L is a target of transcription factor Nrf2.
Journal: Biochemical and biophysical research communications
doi: 10.1016/j.bbrc.2025.152225
Figure Legend Snippet: Fig. 4. Recombinant CD5L (rCD5L) suppresses TGFβ-mediated fibrogenic responses in human lung fibroblast cells. Protein levels of COL1A1, FN1, and α-SMA in IMR-90 cells pre-treated with vehicle or rCD5L (0.4 μg/mL) for 3 h, followed by treatment with vehicle or TGFβ (2 ng/mL) for a further 24 h. Representative blots and quantification relative to α-tubulin are shown. Unpaired two-sample Student’s t-test (2-tailed) was used to analyze the difference between rCD5L-treated and vehicle-treated cells, either without or with TGFβ treatment.
Techniques Used: Recombinant
Related Articles
Recombinant:Article Title: Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis Article Snippet: For experimental procedures, cells were seeded in multiwell plates, and subconfluent cells were starved in a medium supplemented with 1% FBS for 24 h before the addition of a medium containing 5 mM (NG, normal glucose), 22 mM of glucose (high glucose, HG,) (D-Glucose G7021, Sigma–Aldrich) or vehicle (PBS) for 72 h in the presence or absence of 50 μg/mL human purified oxLDL (BT-910 Alfa Aesar J65591) for the last 24 h. Treatments did not induce cytotoxicity analyzed by the MTT assay (Roche Diagnostics, Indianapolis, IN, USA). .. In additional assays, the cells were co-incubated with 1 μg/mL endotoxin-free Article Title: CD5L induces inflammation and survival in RA-FLS through ERK1/2 MAPK pathway. Article Snippet: .. Article Title: Extracellular vesicles derived from GMSCs stimulated with TNF-α and IFN-α promote M2 macrophage polarization via enhanced CD73 and CD5L expression Article Snippet: .. Recombinant human TNF-α, IFN-α, IFN-γ, IL-4, IL-13, and macrophage-colony stimulating factor (M-CSF) were purchased from BioLegend (San Diego, CA, USA) and Control:Article Title: Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis Article Snippet: For experimental procedures, cells were seeded in multiwell plates, and subconfluent cells were starved in a medium supplemented with 1% FBS for 24 h before the addition of a medium containing 5 mM (NG, normal glucose), 22 mM of glucose (high glucose, HG,) (D-Glucose G7021, Sigma–Aldrich) or vehicle (PBS) for 72 h in the presence or absence of 50 μg/mL human purified oxLDL (BT-910 Alfa Aesar J65591) for the last 24 h. Treatments did not induce cytotoxicity analyzed by the MTT assay (Roche Diagnostics, Indianapolis, IN, USA). .. In additional assays, the cells were co-incubated with 1 μg/mL endotoxin-free Sterility:Article Title: CD5L is a target of transcription factor Nrf2. Article Snippet: They were plated on 6-well plates (3 × 105 per well), grown for 24 h, and the media was replaced with a low-serum-containing DMEM (0.1 % FBS) for a further 16 h. Cells were then pre-treated with either vehicle or 0.4 μg/mL rCD5L for 3 h, and treated with either vehicle or 2 ng/mL recombinant human TGFβ1 for a further 24 h. The vehicle for the TGF-β1 treatment was sterile reconstitution buffer containing 0.1 % BSA Fraction V (ThermoFisher Scientific) in 4 mM HCl made with ultrapure water. .. |

